View Author
patient myeloma thalidomide dexamethasone study therapy lenalidomide treatment cancer trial combination melphalan factor bortezomib university blood regimen disease group month prednisone department survival hospital phase palumbo randomized hematology response signi incidence chemotherapy agent prophylaxi thrombosis serum high-dose dexamethasone venou diagnosis ef ficacy table high-dose venous thromboembolism doxorubicin outcome increase leukemia warfarin result cycle oncol grade recommendation erasmus mc anticoagulant prophylaxis novel agents risk factors cyclophosphamide novel myeloma patients guideline group guidelines cancer patients days 1-4 criteria center aspirin maintenance comorbidity level thromboembolism signi ficantly transplantation ն 75 years j clin oncol celgene institute medicine 100 ml effect
4 Most Recent Publications
|
Personalized therapy in multiple myeloma according to patient age and vulnerability: A report of the European Myeloma Network (EMN)
(Article)
Palumbo, A. Bringhen, S. Zweegman, S. Terpos, E. Davies, F. Driessen, C. Gimsing, P. Gramatzki, M. Hajek, R. Johnsen, H.E. Da Costa, F.L. Sezer, O. Ludwig, H. Spencer, A. Beksaç, M. Morgan, G. Einsele, H. San Miguel, J. Sonneveld, P. Dimopoulos, M.A. Bladé, J. Mateos, M.V. Rosiñol, L. Boccadoro, M. Cavo, M. Lokhorst, H.M. |
2011-10-27
|
|
European Myeloma Network: The 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma
(Article)
Engelhardt, M. Udi, J. Driessen, C. Patriarca, F. Gramatzki, M. Terpos, E. Sezer, O. Kropff, M. Straka, C. Johnsen, H.E. Waage, A. Boegsted, M. Kleber, M. Lokhorst, H.M. Hjek, R. Morgan, G. Boccadoro, M. Ludwig, H. Cavo, M. Polliack, A. Sonneveld, P. Einsele, H. Palumbo, A. Spencer, A. Rocci, A. Knop, S. Bruno, B. Bringhen, S. Pérez-Simn, J.A. Zweegman, S. |
2010-11-01
|
|
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
(Article)
Palumbo, A. Sezer, O. Kumar, S. Hajek, R. Giralt, S. Bringhen, S. Anderson, K.C. Richardson, P.G. Cavo, M. Davies, F. Bladé, J. Einsele, H. Kyle, R. Dimopoulos, M.A. Spencer, A. Dispenzieri, A. Reiman, T. Shimizu, K. Lee, J.H. Attal, M. Boccadoro, M. Mateos, M.V. Chen, W. Miguel, J.S. Ludwig, H. Joshua, D. Chim, J. Hungria, V. Turesson, I. Durie, B.G.M. Lonial, S. Orlowski, R.Z. Moreau, P. Niesvizky, R. Morgan, G. Comenzo, R.L. Sonneveld, P. |
2009-06-08
|
|
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
(Article)
Palumbo, A. Rajkumar, S.V. Attal, M. Belch, A. Knop, S. Joshua, D. Sezer, O. Ludwig, H. Vesole, D. Bladé, J. Kyle, R. Westin, J. Dimopoulos, M.A. Weber, D. Bringhen, S. Niesvizky, R. Waage, A. Lilienfeld-Toal, M. Von Lonial, S. Morgan, G. Orlowski, R.Z. Shimizu, K. Anderson, K.C. Richardson, P.G. Boccadoro, M. Durie, B.G.M. Sonneveld, P. Hussein, M. San Miguel, J-F. Barlogie, B. Harousseau, J-L. Zonder, J.A. Cavo, M. Zangari, M. |
2008-02-01
|
